Toutes les photos(1)

Principaux documents

Voir toute la documentation

374962

4-Guanidinobenzoic acid hydrochloride

Name: 4-Guanidinobenzoic acid hydrochloride
Brand: ALDRICH

99%

Synonyme(s) :

4-Guanidobenzoic acid hydrochloride

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Toutes les photos(1)

About This Item

Formule linéaire :

H₂NC(=NH)NHC₆H₄CO₂H · HCl

Numéro CAS:

42823-46-1

Poids moléculaire :

215.64

Numéro Beilstein :

3718032

Numéro CE :

255-956-3

Numéro MDL:

MFCD00040587

Code UNSPSC :

12352100

ID de substance PubChem :

24863351

Nomenclature NACRES :

NA.22

Produits recommandés

Slide 1 of 1

1 of 1

Sigma-Aldrich

262242

1,4-Phenylene diisocyanate

Pureté

99%

Forme

solid

Pf

285 °C (dec.) (lit.)

Température de stockage

2-8°C

Chaîne SMILES

Cl[H].NC(=N)Nc1ccc(cc1)C(O)=O

InChI

1S/C8H9N3O2.ClH/c9-8(10)11-6-3-1-5(2-4-6)7(12)13;/h1-4H,(H,12,13)(H4,9,10,11);1H

Clé InChI

YETFLAUJROGBMC-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

4-Guanidinobenzoic acid hydrochloride is a guanidine derivative. Quality standard of 4-guanidinobenzoic acid hydrochloride has been investigated.

Application

4-Guanidinobenzoic acid hydrochloride may be used in ELISA inhibition assay of mouse antiserum. It may be used in the synthesis of human acrosin inhibitor 4′-acetaminophenyl 4-guanidinobenzoate hydrochloride.2

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 1

1 of 1

Sigma-Aldrich

402516

1H-Pyrazole-1-carboxamidine hydrochloride

Additional mechanisms of nafamostat mesilate-associated hyperkalaemia.

S Ookawara et al.

European journal of clinical pharmacology, 51(2), 149-151 (1996-01-01)

Nafamostat mesilate, a potent protease inhibitor, is widely used for the treatment of pancreatitis, disseminated intravascular coagulation and as an anticoagulant in haemodialysis. However, hyperkalaemia associated with nafamostat mesilate has been reported. It is thought to be due to decreased

The kinetic and structural characterization of the reaction of nafamostat with bovine pancreatic trypsin.

M K Ramjee et al.

Thrombosis research, 98(6), 559-569 (2000-07-19)

Nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor, is active against a number of the serine proteases involved in coagulation. This has been proposed as the basis of its anticoagulant activity. We investigated the reaction of Nafamostat with bovine pancreatic

Metabolic fate of 14C-camostat mesylate in man, rat and dog after intravenous administration.

I Midgley et al.

Xenobiotica; the fate of foreign compounds in biological systems, 24(1), 79-92 (1994-01-01)

1. The metabolic fate of N,N-dimethylcarbamoylmethyl 4-(4-guanidino[14C]benzoyloxy)phenylacetate methanesulphonate (14C-camostat mesylate) was investigated after i.v. administration to man (12-h infusion), and to rat and dog (bolus injection). 2. Renal excretion (mainly in 24 h) accounted for at least 80% dose in

Di-ya L, et al.

Chinese Pharmaceutical Journal, 3, 28-28 (2010)

Mechanisms of the hyperkalaemia caused by nafamostat mesilate: effects of its two metabolites on Na+ and K+ transport properties in the rabbit cortical collecting duct.

S Muto et al.

British journal of pharmacology, 111(1), 173-178 (1994-01-01)

1. The present experiments were undertaken to determine the mechanism(s) of hyperkalaemia caused by nafamostat mesilate (NM), a serine-protease inhibitor. 2. We investigated the effects of luminal addition of two metabolites of NM, p-guanidinobenzoic acid (PGBA) and 6-amidino-2-naphthol (AN), on

Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique